retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr - of 18 patients remain alive of those recruited since the study reopened in 2021.longer than expected patient survival da... 
CEO Of Digital Media Online